Skip to main content
. Author manuscript; available in PMC: 2020 Nov 13.
Published in final edited form as: J Mol Biol Methods. 2020 Jul 5;3(2):107.

Table 3:

Sry (Sry/B2m) values within each treatment group for gDNA and mRNA analysis of rat placenta.

Analysis Treatment Male Sry/B2m (Mean ± SEM) Female Sry/B2m (Mean ± SEM) p-valuea
gDNA Control 1.420 ± 0.1460 7.258 × 10−4 ± 2.951 × 10−4 0.0001
gDNA NAC 1.085 ± 0.1583 3.752 × 10−3 ± 3.086 × 10−3 0.0002
gDNA AOAA 1.886 ± 0.9149 9.275 × 10−4 ± 5.243 × 10−3 0.0095
gDNA TCE 1.673 ± 0.1342 3.356 × 10−3 ± 1.022 × 10−3 0.0002
gDNA TCE + NAC 1.158 ± 0.1826 1.199 × 10−3 ± 7.722 × 10−4 0.0002
gDNA TCE + AOAA 1.090 ± 0.1489 5.600 × 10−4 ± 1.852 10−4 0.0006
mRNA Control 1.867 ± 0.5535 0 <0.0001
mRNA NAC 0.9734 ± 0.2341 0 0.0002
mRNA AOAA 1.319 ± 0.4043 0 0.0095
mRNA TCE 1.271 ± 0.3541 0 0.0002
mRNA TCE + NAC 4.441 ± 2.304 0 0.0002
mRNA TCE + AOAA 0.4455 ± 0.08977 0 0.0006
a

p-values were computed using the two-tailed Mann-Whitney test to compare males and females. Sample sizes are shown in Table 2.